These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 4818222

  • 1. [Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
    Grundmann E, Fritzsche R.
    Dtsch Med Wochenschr; 1974 Feb 15; 99(7):269-73. PubMed ID: 4818222
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M, Teillet F, Weisgerber C, Dana M, Jacquillat C, Bernard J.
    Rev Prat; 1974 Oct 11; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract] [Full Text] [Related]

  • 4. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E, Kende G, Many A, Ramot B.
    Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045
    [No Abstract] [Full Text] [Related]

  • 5. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May 01; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 6. Hodgkin's disease. A historical perspective.
    Avilés A, Díaz-Maqueo JC, Torras V, Ayala JR, Cortés HD.
    Arch Invest Med (Mex); 1991 May 01; 22(1):27-33. PubMed ID: 1726450
    [Abstract] [Full Text] [Related]

  • 7. [Polychemotherapy of Hodgkin's disease (author's transl)].
    Jacquillat CL, Weil M, Auclerc G, Delbrück H, Chastang CL, Chelloul N, Boiron M, Bernard J.
    Dtsch Med Wochenschr; 1975 Apr 11; 100(15):785-90. PubMed ID: 1122828
    [Abstract] [Full Text] [Related]

  • 8. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG, Pieresca C, Cavanna L, Corbella F, Vallisa D, Federico M, Formisano R, Carotenuto M, Merli F, Callea V, Angrilli F, Silingardi V.
    Haematologica; 1996 Apr 11; 81(6):503-12. PubMed ID: 9009437
    [Abstract] [Full Text] [Related]

  • 9. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F, Baccarani M, Barbieri E, Fiacchini M, Gobbi M, Tura S, Baccarani M.
    Haematologica; 1975 Mar 11; 60(1):73-84. PubMed ID: 806500
    [No Abstract] [Full Text] [Related]

  • 10. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT.
    Natl Cancer Inst Monogr; 1973 May 11; 36():373-9. PubMed ID: 4744596
    [No Abstract] [Full Text] [Related]

  • 11. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 11; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 11; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 13. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J, Mauch P, Rosenthal DS, Canellos GP.
    Cancer Treat Rep; 1982 Apr 11; 66(4):1015-22. PubMed ID: 7074629
    [Abstract] [Full Text] [Related]

  • 14. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM, Asselain B, Bayle C, Teillet F, Clot P, Dana M, Katz M, Brière J, Jacquillat C, Bernard J.
    Bull Cancer; 1981 Apr 11; 68(2):190-9. PubMed ID: 7016225
    [No Abstract] [Full Text] [Related]

  • 15. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG.
    Dtsch Med Wochenschr; 1976 Aug 06; 101(32):1177-82. PubMed ID: 59661
    [Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy in Hodgkin's disease].
    Andersson T, Landberg T, Möller TR.
    Lakartidningen; 1974 May 02; 71(18):1844-6. PubMed ID: 4597780
    [No Abstract] [Full Text] [Related]

  • 17. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM.
    Sangre (Barc); 1998 Jun 02; 43(3):179-84. PubMed ID: 9741222
    [Abstract] [Full Text] [Related]

  • 18. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN, Gregory W, Hudson GV, Devereux S, Goldstone AH, Hancock B, Winfield D, MacMillan AK, Hoskin P, Newland AC, Milligan D, Linch DC.
    Br J Cancer; 1999 Oct 02; 81(3):476-83. PubMed ID: 10507773
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH.
    Natl Cancer Inst Monogr; 1973 May 02; 36():395-402. PubMed ID: 4744597
    [No Abstract] [Full Text] [Related]

  • 20. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
    Avilés A, Díaz-Maqueo JC, García EL, Torras V, López-Vancell D.
    Arch Invest Med (Mex); 1991 May 02; 22(1):45-50. PubMed ID: 1819976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.